Age and CD4 count of vertically HIV-infected children at the time of diagnosis: What are independent predictors for being symptomatic and CD4 counts drop?

Journal of Tropical Pediatrics

Volumn 57, Issue 1, 2011, Pages 14-23

  Berhan, Yifru ^a  

^a HAWASSA UNIVERSITY   (Ethiopia)

Author keywords

CD4 count; Children; Ethiopia; Severe immunosuppression; Symptomatic

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; ETHIOPIA; ETHNICITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN DISEASE; TUBERCULOSIS;

ADOLESCENT; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDIES; ETHIOPIA; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSION; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VIRAL LOAD;

EID: 79251604489     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq032     Document Type: Article

References (23)

1. Mofenson LM, Munderi P. Safety of antiretroviral prophylaxis of perinatal transmission of HIV infected pregnant women and their children. J Acquir Immune Defic Syndr 2002;30:200-15.
2. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Motherto-Child HIV-1 Transmission Study Group. Pediatrics 1999;104:e56.
3. Goulder PJ, Jeena P, Tudor-Williams G, et al. Pediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management. Br Med Bull 2001;58:89-108.
4. Little K, Thorne C, Luo C, et al. Disease progression in children with vertically-acquired HIV infection in Sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res 2007;5:139-53.
5. Domachowske JB. Pediatric human immunodeficiency virus infection. Clin Microbiol Rev 1996;9:448-68.
6. Gray L, Newell ML, Thorne C, et al. Fluctuation in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics 2001;108:116-22.
7. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA 2005;293:2221-31.
8. Niehues T, Lyall H. Antiretroviral therapy in children. In: Rockstroh-Kamps Hoffmann (ed.). Paris, Cagliari, Wuppertal: HIV Medicine. Flying Publisher, 2006; pp. 375-9.
9. Hernandez M, George DM, Laura GH, et al. Older children and adolescents living with perinatally acquired HIV infection. Pediatrics 1995;95:657-63.
10. Ferris MG, Gordon ES. Natural history and classification of pediatric HIV infection. UpToDate Desk top 17.1. 2009.
11. Centers for Disease Control and Prevention (CDC). Revised classification system of HIV Infection in children <13 years of age. MMWR Recomm Rep 1994;43:1.
12. Madhivanan P, Mothi SN, Kumarasamy N, et al. Clinical manifestations of HIV infected children. Indian J Pediatr 2003;70:615-20.
13. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS epidemic. http://www.unaids.org (June 2008, date last accessed).
14. Ethiopia Demographic and Health Survey 2005. 16.11:252-6.
15. Bland M. An Introduction to Medical Statistics 3rd edn. Oxford University Press, 2000; pp. 335-46.
16. Ferris MG, Kline M, Torchia MM, et al. UpToDate version 17.1. Epidemiology of pediatric HIV infection.
17. Mark MK, Kektinwa A, Maganda A, et al. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient care STDS 2008;22:245-51.
18. Feucht UD, Kinzer M, Kruger M. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr 2007;53:398-402.
19. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007;7:13.
20. Zanchetta M, Ansemi A, Vendrame D, et al. Early therapy in HIV-1 infected children: effect on HIV-1 dynamics and HIV-1 immune response. Antivir Ther 2008;13:47-55.
21. Bruchfeld J, Aderaye G, Palme IB, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without HIV infection. J Clin Microbiol 2002;5:1636-43.
22. Sarah MW, Samir SS, Andrew PS, et al. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics 2008;121:e150-6.
23. Federal HIV/AIDS Prevention and Control Office. Guideline for Paediatric HIV/AIDS Care and Treatment in Ethiopia. July 2008.